Retraction notice to “Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo” [Int. J. Biol. Macromol. 186 (2021) 849–863]
Armin Mahmoud Salehi Khesht(Tabriz University of Medical Sciences), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Mahdis Mohammadi(Golestan University), Naime Majidi Zolbanin(Urmia University), Leili Aghebati‐Maleki(Tabriz University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Reza Jafari(Urmia University), Hadi Hassannia(Mazandaran University of Medical Sciences), Angelina Olegovna Zekiy(Sechenov University), Ata Mahmoodpoor(Tabriz University of Medical Sciences), Parisa Sahami Gilan(Kermanshah University of Medical Sciences), Lyubov A. Melnikova(Government of Russia), Vahid Karpisheh(Tabriz University of Medical Sciences)
Cited by 0
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review
|Stem Cell Research & Therapy|2022|404
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
RETRACTED ARTICLE: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
|Stem Cell Research & Therapy|2021|275
The paradox of Th17 cell functions in tumor immunity
|Cellular Immunology|2017|222